{"url":"https://lda.senate.gov/api/v1/filings/c2e3da5e-e076-4fb2-b144-9c32fb213498/","filing_uuid":"c2e3da5e-e076-4fb2-b144-9c32fb213498","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2022,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c2e3da5e-e076-4fb2-b144-9c32fb213498/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Zachary Williams","dt_posted":"2022-07-17T19:07:23-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 6th Street NW","registrant_address_2":"8th Fl","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":400976792,"url":"https://lda.senate.gov/api/v1/registrants/400976792/","house_registrant_id":null,"name":"FORBES-TATE","description":"Government Relations Firm.","address_1":"777 6th Street NW","address_2":"8th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ZACHARY WILLIAMS","contact_telephone":"+1 202-638-0125","dt_updated":"2026-07-20T16:54:02.529740-04:00"},"client":{"id":196654,"url":"https://lda.senate.gov/api/v1/clients/196654/","client_id":1507,"name":"ULTRAGENYX PHARMACEUTICAL","general_description":"Clinical-state biopharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-11-07"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to rare disease, drug development, reimbursement, and market access.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65301,"prefix":null,"prefix_display":null,"first_name":"EDWARD","nickname":null,"middle_name":"C.","last_name":"RENO","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":67969,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":null,"last_name":"PALMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64326,"prefix":null,"prefix_display":null,"first_name":"DERRICK","nickname":null,"middle_name":"M","last_name":"WHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63568,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"SADOSKY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72734,"prefix":null,"prefix_display":null,"first_name":"BARRETT","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":115654,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"DIOGUARDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139726,"prefix":"mr","prefix_display":"MR.","first_name":"BENJAMIN","nickname":"TAYLOR","middle_name":null,"last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":"Communications Director, Rep. David Young (2017)","new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}